Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VEEV · against 60 other Healthcare companies of similar size
Ranked #51 of 61 · scores higher than 15% of peers
Bars: peers in each 10-point band of the valuation score9 peers with a valuation score of 40–49, including VEEV · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | VEEV | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 58 reported | 2.0% | 3.0% | 23% | 30% | |
| EBITDA yieldHigher is better · 62 reported | 2.6% | 6.1% | 10% | 50% | |
| Free cash flow yieldHigher is better · 44 reported | 3.4% | 4.0% | 44% | 20% | |
| Book yieldHigher is better · 57 reported | 14.8% | 22.1% | 25% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 2 | 78.1B USD | 89 | 60 | |
| 3 | 97.5B USD | 87 | 67 | |
| 4 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 5 | 45.9B USD | 84 | 61 | |
| 48 | 28.6B USD | 48 | 60 | |
| 49 | 43.30T KRW (≈$31.2B) | 47 | 68 | |
| 49 | 54.9B USD | 47 | 59 | |
| 51 | 40.2B USD | 46 | 73 | |
| 51 | 49.1B USD | 46 | 69 | |
| 53 | 66.3B USD | 44 | 30 | |
| 54 | 56.7B USD | 42 | 79 | |
| 55 | 2.67T INR (≈$32.1B) | 39 | 68 | |
| 56 | 45.2B USD | 38 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score